BRZE Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Braze Inc (BRZE) is a good buy right now for a beginner long-term investor with $50,000-$100,000 available. The stock is supported by strong revenue growth, improving operating momentum, broadly positive analyst sentiment, and heavy hedge fund buying. Given the current price near support and the absence of a strong bearish catalyst, I would rate it a buy now rather than waiting.
BRZE is in a mixed-to-slightly weak short-term technical setup, but not a breakdown. Price closed at 22.45, just below the pivot of 23.062 and above first support at 21.877. RSI_6 at 46.12 is neutral, so there is no oversold or overbought pressure. MACD histogram is -0.11 and negatively expanding, which signals near-term momentum is soft. Moving averages are converging, suggesting a potential inflection point rather than a strong trend either way. Overall, the chart is range-bound with mild downside pressure, but current levels are close enough to support to justify a long-term entry.
["Strong Q4/FY26 financial performance with revenue up 27.91% YoY.", "Organic revenue growth acceleration and improved bookings momentum noted by multiple analysts.", "FY27 guidance appears ahead of Street expectations, especially on growth.", "Inaugural $100 million buyback program supports shareholder returns.", "Hedge funds are aggressively buying, with buying amount up 105.34% over the last quarter.", "Analyst community remains broadly bullish, with multiple Buy/Overweight/Outperform ratings."]
["Gross margin declined to 65.48%, down 5.46% YoY.", "Net income remains negative at -31.6 million, so profitability is not yet established.", "MACD is negative and weakening, indicating soft near-term momentum.", "Several analysts cut price targets due to broader software multiple compression.", "No recent news catalysts this week, so near-term upside may be slower without fresh developments."]
Latest quarter was Q4 of FY2026. Revenue rose to $205.17 million, up 27.91% YoY, showing strong growth momentum. Net income improved to -$31.6 million, a 83.83% YoY improvement, and EPS improved to -0.29, down 70.59% in loss severity. Gross margin fell to 65.48%, down 5.46% YoY, which is the main weakness in the report. Overall, the latest quarter showed strong top-line acceleration and better loss control, but profitability is still negative.
Recent analyst trend is broadly positive, though price targets have been adjusted lower because of software sector rerating. Citi, UBS, Oppenheimer, Stifel, Piper Sandler, and Goldman all kept Buy/Outperform-type ratings, while DA Davidson, BTIG, Canaccord, and Barclays also stayed constructive. Most firms cited strong Q4 results, accelerating organic growth, improving bookings, and FY27 guidance ahead of expectations. The Wall Street pro view is that Braze has durable growth, share gains, and improving execution. The con view is that valuation multiples across software are compressing, and some firms flagged possible FY27 deceleration versus the very strong recent run rate.
